QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 employers-struggle-with-drug-test-policies-amid-varying-state-laws-cheating-on-drug-tests-reaches-30-year-high

Cheating on drug tests among American workers has reached a 30-year high, with Quest Diagnostics Inc. reporting 31,000 tampered...

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 barclays-maintains-equal-weight-on-quest-diagnostics-raises-price-target-to-144

Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from...

 citigroup-maintains-neutral-on-quest-diagnostics-raises-price-target-to-145

Citigroup analyst Patrick Donnelly maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $1...

 ubs-maintains-neutral-on-quest-diagnostics-raises-price-target-to-146

UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $139 to $146.

 truist-securities-maintains-hold-on-quest-diagnostics-raises-price-target-to-150

Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target fro...

 mizuho-maintains-buy-on-quest-diagnostics-raises-price-target-to-155

Mizuho analyst Ann Hynes maintains Quest Diagnostics (NYSE:DGX) with a Buy and raises the price target from $150 to $155.

 quest-diagnostics-says-sales-in-q1-increased-for-the-first-time-since-the-height-of-pandemic

Latest financial insights from Quest Diagnostics. Q1 results beat estimates with adjusted EPS of $2.04 and sales of $2.34 billi...

 earnings-scheduled-for-april-23-2024

Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of...

 quest-diagnostics-q1-2024-adj-eps-204-beats-186-estimate-sales-2366b-beat-2287b-estimate

Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.86 ...

 us-stocks-set-to-open-fresh-week-higher-on-big-tech-earnings-hopes-analyst-warns-any-letdown-could-push-market-deeper-into-oversold-territory

Wall Street appears to be shrugging off rate worries as major stock index futures were moderately higher in early pre-market tr...

 can-magnificent-7-help-script-market-turnaround-earnings-pick-up-pace-with-microsoft-meta-alphabet-and-tesla-expected-this-week

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

 truist-securities-reiterates-hold-on-quest-diagnostics-maintains-145-price-target

Truist Securities analyst David Macdonald reiterates Quest Diagnostics (NYSE:DGX) with a Hold and maintains $145 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION